Financial reports
10-K/A
2021 FY
Annual report (amended)
23 Aug 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
29 Mar 22
10-K/A
2020 FY
Annual report (amended)
12 Jan 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
11 Aug 21
Current reports
8-K
Health Assurance Acquisition Corp. will redeem its Public Shares and will not consummate an initial business combination
27 Oct 22
8-K
Departure of Directors or Certain Officers
5 Apr 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
23 Feb 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
27 Dec 21
8-K
Departure of Directors or Certain Officers
2 Nov 21
8-K
Departure of Directors or Certain Officers
20 Aug 21
8-K
Health Assurance Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
4 Jun 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
20 May 21
8-K
Other Events
30 Dec 20
8-K/A
Entry into a Material Definitive Agreement
23 Nov 20
Registration and prospectus
15-12G
Securities registration termination
14 Nov 22
25-NSE
Exchange delisting
3 Nov 22
424B4
Prospectus supplement with pricing info
16 Nov 20
8-A12B
Registration of securities on exchange
12 Nov 20
S-1/A
IPO registration (amended)
12 Nov 20
S-1/A
IPO registration (amended)
9 Nov 20
S-1/A
IPO registration (amended)
6 Nov 20
S-1
IPO registration
26 Oct 20
DRS
Draft registration statement
28 Sep 20
Proxies
No filings
Other
UPLOAD
Letter from SEC
25 Aug 22
CORRESP
Correspondence with SEC
23 Aug 22
UPLOAD
Letter from SEC
12 Aug 22
EFFECT
Notice of effectiveness
13 Nov 20
CERT
Certification of approval for exchange listing
12 Nov 20
CORRESP
Correspondence with SEC
12 Nov 20
CORRESP
Correspondence with SEC
10 Nov 20
CORRESP
Correspondence with SEC
10 Nov 20
UPLOAD
Letter from SEC
10 Nov 20
CORRESP
Correspondence with SEC
9 Nov 20
Ownership
SC 13G/A
STAD MARC
14 Feb 23
4
Change in insider ownership
23 Nov 22
SC 13G/A
Atlas Merchant Capital LLC
23 Nov 22
3
Initial statement of insider ownership
7 Nov 22
SC 13G
Atlas Merchant Capital LLC
7 Nov 22
3
MARK JOSEPH ALLEN
11 Apr 22
SC 13G
Sculptor Capital LP
4 Mar 22
SC 13G/A
HAAC Sponsor, LLC
14 Feb 22
SC 13G
Weiss Asset Management LP
11 Feb 22
SC 13G
BlackRock Inc.
8 Feb 22